Active ingredients: Amikacin
AMIKIN INJECTION 100MG/2ML.
Solution for administration to human beings by injection.
Each vial contains in 2 mL amikacin sulfate equivalent to amikacin activity 100 mg (100,000 international units).
Excipient with known effect: Each vial contains 2.64 mg (0.13 mmol) sodium metabisulfite (E223).
For the full list of excipients, see section 6.1.
Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins.
Sodium metabisulfite (E223)
Sodium citrate
Sulphuric acid
Water for injection
Five 2 mL flint glass Type 1 vial with butyl rubber stopper and aluminium seal in a cardboard carton.
Bristol-Myers Squibb Pharmaceuticals Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH
PL 11184/0136
Date of first authorisation: 26th August 1976
Date of latest renewal: 25th November 2005